Home › Parkinson's Disease › District of Columbia
Parkinson's Disease clinical trials in District of Columbia
4 studies for Parkinson's Disease are looking for participants at sites in District of Columbia.
Cities in District of Columbia
RESvEraTrol in Parkinson's Disease (RESET)
- Georgetown University Hospital, Washington D.C.
RecruitingPhase 2
Ages 55 to 85 · All sexes · Updated Sep 18, 2026 · NCT07592767A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- Georgetown University, Washington D.C.
RecruitingPhase 3
Ages 50 to 85 · All sexes · Updated Sep 3, 2026 · NCT07174310A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- MedStar Georgetown University Hospital, Washington D.C.
RecruitingPhase 3
Ages 45 to 75 · All sexes · Updated Aug 4, 2026 · NCT06944522Social & QoL Behaviors in Parkinson's Disease
- The George Washington University, Washington D.C.
RecruitingObservational studyHealthy volunteers welcome
Ages 40 and older · All sexes · Updated Feb 13, 2026 · NCT06385184From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.